Teva Acquires Top German Generics Maker for $5 Billion
Friday, March 19, 2010 - 00:14
in Earth & Climate
The acquisition of Ratiopharm catapults Teva, the global leader in generic drugs, from fifth place among German generic players to the No. 2 spot.